Illumina teams up with Tempus to expand DNA profiling beyond cancer
The companies said they will work together to train artificial intelligence algorithms on genomic data, while also collecting evidence on the clinical benefits of molecular diagnostics and comprehensive genomic profiling in everyday healthcare.
The companies said they will work together to train artificial intelligence algorithms on genomic data, while also collecting evidence on the clinical benefits of molecular diagnostics and comprehensive genomic profiling in everyday healthcare.
